Understanding how clinical trials are delivered starts with clarity on the roles that shape them. Our latest blog explains how sponsors set the research agenda and retain oversight, how CROs manage operational delivery...
ICON experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
Fights over Tylenol, SSRIs highlight the enduring lack of pregnant women in drug trials
Read the article to learn why the exclusion of pregnant women from clinical trials continues to fuel data gaps, misinformation, and missed opportunities for safer, more effective treatments.
-
ACRO Good Clinical Podcast: Paediatric clinical trials: Compassion in action
Jacqui Whiteway, Senior Director & Paediatric Strategy Liaison, Centre for Paediatric Clinical Development at ICON participates in this discussion on what makes paediatric clinical trials unique and how the industry can make participation easier for paediatric patients and their families.
-
Paediatric clinical trials for obesity treatment
In this article, ICON experts Alan Baldridge and Heather Peterson discuss the prevalence of paediatric obesity and assess clinical trials of its treatments.
-
Accessibility in rare disease paediatric clinical trials
In this International Pharmaceutical Industry article, ICON experts Kirsten Sherman Cervati and William C. Maier discuss strategies to make clinical trials more accessible for Paediatric patients and their families.
-
Sharing clinical trial results with paediatric participants
Kirsten Sherman Cervati contributes to this media article which discusses the considerations for returning results to paediatric participants.
